Coronavirus News and Research

RSS

How likely is SARS-CoV-2 reinfection?

The coronavirus disease 2019 (COVID-19) pandemic has already caused over 117.6 million confirmed cases the world over. Yet, researchers debate the exact incidence of reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19’s causative pathogen.

10 Mar 2021

Pfizer COVID-19 vaccine elicits antibodies in blood and breastmilk simultaneously, finds study

A new study adds to the sum of knowledge around this issue, showing a highly synchronized and rapid development of an antibody response in breast milk and serum, which reached stable levels around two weeks after the second dose of the vaccine was administered.

10 Mar 2021

Study: COVID-19 pandemic can affect mothers and infants through immune pathways

If past natural disasters have taught us anything about their effects on pregnant women and developing babies, it is to pay close attention, for the added stress will surely have an impact on them.

10 Mar 2021

Survey shows that 43% of respondents have already tested for coronavirus

According to the current BfR-Corona-Monitor of the German Federal Institute for Risk Assessment (BfR), 43 percent of the respondents have already had themselves tested for the virus.

10 Mar 2021

New SARS-CoV-2 vaccine candidate produces strong immune response, prevents SARS-CoV-2 infection

A new SARS-CoV-2 vaccine candidate, developed by giving a key protein's gene a ride into the body while encased in a measles vaccine, has been shown to produce a strong immune response and prevent SARS-CoV-2 infection and lung disease in multiple animal studies.

10 Mar 2021

Researchers discover new COVID-19 variants in three South African provinces

Variants of the coronavirus are appearing in different parts of the world, many of them spreading with alarming speed.

10 Mar 2021

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

In a recent bioRxiv* preprint paper, researchers isolated anti-RBD nanobodies from llamas and “nanomice” (they engineered to produce VHHs cloned from alpacas, dromedaries and camels).

10 Mar 2021

Analysis shows moderate evidence for SARS-CoV-2 recombination

Recently, a team of researchers from the US performed a comprehensive recombination analysis across all medically relevant human coronaviruses, including 158,118 public seasonal hCoV, SARS-CoV-1, SARS-CoV-2, and MERS-CoV genome sequences with the help of the RDP4 software. They aimed at identifying the current and future risks of the emergence of recombinants of SARS-CoV-2

10 Mar 2021

2% of individuals carry 90% of SARS-CoV-2 virions: Study of 72,500 tests

In a new study published on the medRxiv* preprint server, researchers analyzed viral loads from pre-symptomatic and asymptomatic individuals in an extensive university surveillance program.

9 Mar 2021

SARS-CoV-2 variants rapidly arise in non-human hosts, potential risk for human reinfection

The study, published on the preprint server bioRxiv*, highlights the need to study viral evolution and pathogenesis in human and animal hosts. This could help prevent future outbreaks that may mimic the magnitude of the current COVID-19 pandemic.

9 Mar 2021

Scientists study seven human coronavirus envelope proteins using topology prediction and molecular modeling

A new study by researchers at the University of the Western Cape aimed to determine why some coronaviruses are more virulent than others. The team speculates that the increased flexibility of the PDZ-binding motif (PBM) of SARS-CoV, MERS-CoV, and SARS22 CoV-2 to be more flexible than the PBM of hCoVs 229E, NL63, OC43, and HKU1.

9 Mar 2021

Advanced 3D models and a telemedicine system enable online training in endoscopic sinus surgery

The world's first international online training session utilizing advanced 3D sinus models and a telemedicine system has taken place, highlighting a new mode of medical training in the Covid-19 era.

9 Mar 2021

Vaccine mRNA not found in breast milk after COVID mRNA vaccination

A study conducted by researchers in the United States has found no evidence to suggest that the messenger RNA (mRNA) present in the Pfizer-BioNTech and Moderna vaccines that protect against coronavirus disease 2019 (COVID-19) can be transferred to human breast milk.

9 Mar 2021

UK variant of SARS-CoV-2 could be more deadly than previous strains

Researchers have conducted a study showing that the B.1.1.7 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has emerged in the UK is associated with a significantly increased risk of death compared with the viral strain previously circulating in the country.

9 Mar 2021

Buck scientists develop a predictive model to help identify people at risk for severe COVID-19

Researchers at the Buck Institute analyzed data from the COVID-19 Symptom Tracker app used by 3 million people in the United Kingdom, adding the use of immunosuppressant medication, use of a mobility aid, shortness of breath, fever, and fatigue to the list of symptoms and comorbidities that increase the risk for severe COVID-19.

9 Mar 2021

A genetic variant of TMPRSS2 may confer protection against severe COVID-19

Among a large sample of COVID-19 patients, researchers found that a genetic variant – caused by an amino acid substitution from valine to methionine – is associated with a reduced chance of severe disease.

9 Mar 2021

Researchers examine susceptibility of raccoons and striped skunks to SARS-CoV-2 infection

Researchers from the University of Georgia, USA, have found some members of the superfamily Musteloidea – the group that includes badgers and weasels – appear to not only have no effects of the virus, but do little in spreading it.

9 Mar 2021

Researchers report zoonotic spillover of adapted SARS-CoV-2 from minks to humans

In a recent report made available on bioRxiv* preprint server, researchers from Poland and Finland reveal a spillover event of mink-adapted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from farmed mink to humans after an extensive adaptation process.

9 Mar 2021

Higher levels of airborne pollen increase SARS-CoV-2 infection rates

When airborne pollen levels are higher, increased SARS-CoV-2 infection rates can be observed. These results were determined by a large-scale study conducted by an international team headed by researchers at the Technical University of Munich and the Helmholtz Zentrum München.

9 Mar 2021

SARS-CoV-2's amyloid-driving nucleoprotein could inform future therapeutic research

New research led by researchers at the University of California Los Angeles and the University of Texas Southwestern Medical Center in the US suggests that functional amyloid fibrils could play an integral role in developing COVID-19 treatments.

9 Mar 2021

Coronavirus News and Research

How likely is SARS-CoV-2 reinfection?

Pfizer COVID-19 vaccine elicits antibodies in blood and breastmilk simultaneously, finds study

Study: COVID-19 pandemic can affect mothers and infants through immune pathways

Survey shows that 43% of respondents have already tested for coronavirus

New SARS-CoV-2 vaccine candidate produces strong immune response, prevents SARS-CoV-2 infection

Researchers discover new COVID-19 variants in three South African provinces

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

Analysis shows moderate evidence for SARS-CoV-2 recombination

2% of individuals carry 90% of SARS-CoV-2 virions: Study of 72,500 tests

SARS-CoV-2 variants rapidly arise in non-human hosts, potential risk for human reinfection

Scientists study seven human coronavirus envelope proteins using topology prediction and molecular modeling

Advanced 3D models and a telemedicine system enable online training in endoscopic sinus surgery

Vaccine mRNA not found in breast milk after COVID mRNA vaccination

UK variant of SARS-CoV-2 could be more deadly than previous strains

Buck scientists develop a predictive model to help identify people at risk for severe COVID-19

A genetic variant of TMPRSS2 may confer protection against severe COVID-19

Researchers examine susceptibility of raccoons and striped skunks to SARS-CoV-2 infection

Researchers report zoonotic spillover of adapted SARS-CoV-2 from minks to humans

Higher levels of airborne pollen increase SARS-CoV-2 infection rates

SARS-CoV-2's amyloid-driving nucleoprotein could inform future therapeutic research

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News